However, administration of pioglitazone to non-diabetic PD patients did not affect leukocyte PGC1α mRNA levels [51], and, in wild type mice, it induced either an increase [52] or decrease [53] in liver PGC1α mRNA levels. Here, PPARGC1A is linked to Parkinson disease.